ABOUT VLI RESEARCH INC.
VLI Research Inc is your bridge to new information on ubiquitin and ubiquitin-like-proteins and their role in health and disease. The mission of VLI is to disseminate state of the art information on the ubiquitin pathway and disease and develop network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.
Ubiquitin-based drug discovery is at the exciting initial stage - much like that of kinases and phosphatases fifteen years ago. Enzymes such as deubiquitylating enzymes (DUBs) and ubiquitin ligases, like phosphatases and kinases, play key roles in the control of cellular signal transduction pathways. We believe that ubiquitin is therefore the next leading technology for drug discovery and diagnostics. VLI is positioned as the leading conference organizer to provide a platform for companies to discuss research possibilities, collaborations and business opportunities for this emerging and ground breaking technology.
Founded in 1995, VLI Research strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage of the strategy behind the business.
Contact Us
VLI Research Inc.
Suite 200271 Great Valley Parkway
Malvern, PA 19355 USA
Phone: 610.644.0585 ext. 319
Fax: 610.644.8616
http://www.ubiquitinconference.com
E-mail: luthra@ubiquitinconference.com
